Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of I-PDT with Temoporfin for patients
with Non-Resectable Non-Small-Cell Lung Cancer (NR-NSCLC). Several clinical studies suggested
that photodynamic therapy (PDT) may be an effective treatment for patients with NR-NSCLC. PDT
is a therapy where an external light source, such as laser, is used to activate a
light-sensitive medicine to produce byproducts that can destroy cancer cells. In this study
the investigators will use an experimental light sensitive medicine, Temoporfin, to perform
interstitial PDT (I-PDT). In I-PDT, laser fibers are inserted into the tumor to activate the
light-sensitive medicine.